In recent years, it had been mentioned that BCR may provide independent and complementary prognostic information of adverse clinical outcomes, whether in acute or chronic heart failure [12, 27], and this effect would not be changed or weakened by the use of diuretics or spironolactone [5, 32, 33]. This evidence concerns the gene BCR and congestive heart failure.